Chlorambucil
Top View
- Chlorambucil (Leukeran®)
- Chlorambucil
- Leukeran Tablets
- Developments in Carbohydrate-Based Cancer Therapeutics
- (CLL/SLL) TREATMENT REGIMENS (Part 1 of 3) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- Effect of Frequently Used Chemotherapeutic Drugs on the Cytotoxic Activity of Human Natural Killer Cells
- October 1, 2019
- Evolution of Nitrogen-Based Alkylating Anticancer Agents
- Phase III Randomized Study of Bendamustine Compared with Chlorambucil in Previously Untreated Patients with Chronic Lymphocytic
- Press Release
- Rituximab Plus Bendamustine Or Chlorambucil for Chronic Lymphocytic Leukemia: Primary Analysis of the Randomized, Open-Label MABLE Study
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Bendamustine
- Cost-Effectiveness Analysis of Arsenic Trioxide for the Treatment of Patients with Acute Promyelocytic Leukemia in the US
- Facts 2014-2015
- Potentiation of Anti-Cancer Drug Activity at Low Intratumoral Ph
- Chlorambucil (Leukeran®) (“Klor AM Byoo Sil”)
- Emetogenic Potential of Antineoplastic Agents